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BACKGROUND 
 
 Healthy People 20101 identifies 10 Leading Health Indicators (LHIs), which may 
be used to monitor the nation’s progress in improving its public health efforts.  These 
LHIs are listed in Table 1.  Each of these indicators is a global behavioral risk factor, 
collection of diseases, or social factor that can be measured and tracked.  Regardless of 
the nature of the indicator, each is associated with multiple illnesses or conditions.  
Presently, the nation’s progress towards improving health outcomes related to these 
measures is tracked via changes in incidence rates, mortality rates, as well as other 
objective-specific outcomes via large national datasets.2,3 
 It is difficult for policymakers, health care professionals, and the general public to 
understand how progress made in reducing one indicator, such as injury and violence, 
compares with progress made toward reducing another, such as obesity.  While injury 
and violence (indicator 7) often result in the loss of life, obesity (indicator 2) mostly 
results in morbidity.  For example, while it is easy to understand that the incidence of 
injury and violence has decreased by 5 percent and the incidence of obesity has decreased 
by 2 percent over a given period, it is difficult to interpret the relevance of the changes in 
these incidence rates from an overarching perspective.   
When presented as a summary measure, the 
burden of disease combines morbidity and 
mortality information within a single metric.4,5  
Burden of disease analyses can also summarize 
multiple conditions, such as those conditions 
attributable to a LHI.   
Burden of disease measures tell consumers 
of Healthy People 2010 how many years of full 
health, or health-adjusted life years (HALYs), are 
lost to a particular condition or disease.  (While 
other global outcome measures, such as disease-
free life expectancy, fall under the rubric of burden 
of disease measures, we will not address these 
here.)  Health-adjusted life years and healthy life expectancy (HALE) are standard 
measures of the burden of disease.4-6  Both measures summarize: risk of various diseases 
or conditions that are attributable to a LHI, their prevalence, and their associated health-
related quality of life (HRQL) and mortality. 
The HALY is an umbrella term that includes quality-adjusted life years 
(QALYs),7 which were developed to evaluate economic outcomes from medical 
interventions, disability-adjusted life years (DALYs), which were designed to measure 
global burden of disease,8  and years of healthy life (YHLs), which were designed to 
monitor the health of Americans for Healthy People 2000.9  No summary measure of 
health is currently included in Healthy People 2010. 
Health-adjusted life expectancy can be calculated using any of these measures and 
is equal to the life expectancy at birth in full health.  There are various ways of presenting 
HALE.  For instance, it would be possible to present the difference in HALE for persons 
who do and do not use tobacco (indicator 3)9 or to present cause-deleted HALE, in which 
case the HALE for persons who do not use tobacco would be presented alongside the 
Table 1.  LHIs to be used in 
Healthy People 2010. 
1. Physical Activity 
2. Overweight and Obesity 
3. Tobacco Use 
4. Substance Abuse 
5. Sexual Behavior 
6. Mental Health 
7. Injury and Violence 
8. Environmental Quality 
9. Immunization 
10. Access to care 
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average life expectancy.10  Figure 1 demonstrates some ways in which burden of disease 
measures can be presented, using hypothetical values for the LHIs. 
Using such burden of disease summary measures, it is theoretically possible to: 1) 
concisely communicate the nation’s progress toward addressing each indicator, 2) 
provide information on the number of HALYs gained by improvements in the LHIs, and 
3) prioritize one indicator relative to another in terms of its impact.   
 
Figure 1.  Various ways of presenting burden of disease summary measures for the LHIs 
should Healthy People 2010 objectives be met.  The baseline HALE for the year 1999 
was approximately 65.5 years.2  Hypothetical values have been entered to illustrate how 
such a table might appear. 
 
  HALYs Lost Change in HALE HALE 
1. Physical Activity 44,450,084 0.71 66.21 
2. Overweight and Obesity 38,998,054 0.68 66.18 
3. Tobacco Use 48,778,843 0.79 66.29 
4. Substance Abuse 45,289,098 0.72 66.22 
… … … … 
 
Burden of disease analyses simplify the presentation of health information.  In 
addition to combining morbidity and mortality into a single number, as described earlier, 
they greatly simplify the presentation of information relating to multiple conditions.  One 
problem encountered with Healthy People 2000 was that overall incidence and mortality 
rates of diseases with multiple etiologies were listed under multiple objectives (each with 
a document heading).1  For instance, the overall rate of heart disease appeared under 
document headings for tobacco use, physical activity, nutrition, as well as others 
(including an overall heading for heart disease), causing redundancy and, potentially, 
confusion on the part of the reader.  
To fix this problem, Healthy People 2010 presents the rate as a single objective 
and mentions the association between heart disease and multiple outcomes under each 
objective.  Were burden of disease measures to be used, it would be theoretically be 
possible to provide the number of HALYs lost to tobacco use as a single number that 
incorporates HALYs lost to heart disease, cancer, and other tobacco-associated 
conditions, as can be seen in Figure 1. 
 
Morbidity + Mortality 
*Attributable Risk 
*Disease Prevalence 
Ratio (or Incidence 
Rate) 
*Health-Related 
Quality of Life Score 
*Duration of Illness 
*Mortality Rate 
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Burden of disease data can also help policymakers better understand which 
diseases should be prioritized for public health funding.  For example, in the mid-1990s, 
the World Health Organization began reporting the burden of disease due to major health 
conditions using the disability-adjusted life year (DALY), a burden of disease measure.6 
Prevalent conditions that had previously been followed using mortality as an outcome but 
caused few deaths, such as depression, moved from the bottom of the rankings to near the 
top.  The use of the DALY has allowed policymakers to better understand the impact of a 
range of mental and physical diseases and conditions within societies. 
 
ISSUES AND APPROACHES 
 
The use of burden of disease measures is not without controversy, and the 
calculation of such measures is technically complex, especially when applied to a LHI.    
When estimating the burden of disease due to a LHI, researchers require information on 
attributable risk, prevalence ratios (or incidence rates), HRQL, and mortality rates 
associated with a disease or condition. Depending on the approach used and the disease 
under study, they may also require information on the duration of an illness, and whether 
or not the disease is episodic. 
When applied to broad public health issues, such as the 10 LHIs, it becomes 
necessary to tease apart various risk factors for disease.  For instance, the first three 
indicators–physical activity, tobacco use, and obesity–are each risk factors for heart 
disease.  The burden of heart disease attributable to each of these indicators must be 
calculated separately.  Moreover, exercise may reduce smoking and obesity 
simultaneously.  Mathematical approaches to teasing risk factors apart are broadly known 
as attributable risk calculations.   
The prevalence ratio of most conditions attributable to any given indicator may be 
estimated from large national datasets.  However, large national datasets do not capture 
the incidence rate of diseases well.  They also fail to capture the prevalence of rare 
conditions or conditions for which self-report data presents ethical problems (i.e., mental 
illness or HIV/AIDS).   
One challenge is to obtain a reasonable estimate of HRQL.  To combine lost 
health due to morbidity and mortality into a single metric, morbidity and mortality must 
be measured on the same scale.  Some experts question whether the sacrifices that were 
necessary in creating a broad public health measure such as the DALY,6 used for 
international comparisons, or the YHL,11 used for tracking in Healthy People 2000, have 
succeeded in their attempts to correctly scale morbidity.4 
Mortality due to a condition may be measured using death certificate data,12 
surveys linked to death certificate data,13,14 prospective trials, or mathematical modeling.  
Each of these methods of measuring mortality presents trade-offs in terms of error, the 
extent to which rates can be tracked from year to year, and the ability to link risk factors 
with the number of deaths that occur. In sum, when estimating burden of disease, there 
are many different approaches, all with attendant issues, that must be considered when 
estimating the attributable risk, the measurement of morbidity, and the measurement of 
mortality.   
Compounding these issues, no unified source of data exists that can be used to 
develop a mathematical model of the independent and correlated effects of all 10 LHIs on 
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morbidity and mortality.  Instead, it is necessary to estimate the burden of disease from 
many different sources of information.  Some data can be linked via a process called 
mapping, in which data from two or more sources are linked together.  This process 
introduces unique sources of error and will not likely provide enough information to 
adequately model the burden of disease due to all 10 LHIs.   
While it is not possible to provide a coherent framework for tabulating the burden 
of disease due to the 10 LHIs, we will outline possible methodological approaches for 
measuring incremental annual changes in HALYs or HALE and flag some of the issues 
that have arisen in past efforts.  We also discuss how the burden of disease might be 
tabulated for special populations, such as persons of low income.  We summarize the 
opinions of experts in tackling these critical issues, present standard and theoretical 
approaches to calculating risk, morbidity, and mortality from the public health literature, 
and synthesize this information where possible.  The objective of this report is to draw on 
the strengths of different schools of thought to formulate a menu of methodological 




We began the project with an extensive review of the burden of disease literature.  
This was conducted using a Medline search between the years of 1980 and 2001, a 
ProQuest search for publications beyond the scope of the medical literature, and an 
Internet search for relevant government documents and publications.  We also obtained 
relevant books and publications using library searches. 
Though most approaches to the estimation of burden of disease have been 
published, many of the issues that have arisen in applying these measures have not.  
Therefore, we interviewed experts in the field of burden of disease analysis to obtain their 
ideas and perspectives on how the 10 LHIs might be approached (see Appendix A for a 
list of participants).  These consultants were selected based on 1) their familiarity with 
attributable risk, morbidity measures, and/or mortality estimations, 2) their history of 
working with disparate approaches (to avoid bias toward a particular approach), and 3) 
their experience with working in teams or with government agencies charged with 
calculating the burden of disease. 
We sent each participant a letter of introduction describing the project as well as a 
technical document describing the issues, major datasets that might be used, and some of 
the approaches currently in use.  We then conducted informal telephone interviews using 
open-ended questions to learn how each participant might approach the particular aspect 
of burden of disease measurement for which the expert is familiar.  We also obtained 
information on issues the expert encountered in applying these methods in previous 
research efforts.  Finally, we conducted a more structured interview asking the expert to 
assist us with data issues or methodological approaches specific to each indicator.  Those 
persons with broad expertise in burden of disease analysis were asked to comment on 
draft copies of the synthesized document so that a cohesive framework could be created 
that would link each of the methodological approaches together. 
To present the issues and approaches in a coherent way, we have divided the 
remainder of this document into sections describing major nationally representative 
health datasets, the estimation of attributable risk, measures used for estimating 
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morbidity, and methods for estimating mortality.  The final section describes issues and 




Healthy People 2000 used a wide variety of nationally representative datasets to 
track the nation’s progress toward meeting the objectives outlined in that project.  
Foremost among these were the National Health Interview Survey (NHIS), the Medical 
Expenditure Panel Survey (MEPS), the National Health and Nutrition Examination 
Survey (NHANES), the Multiple Cause of Death Datafile, and the Behavioral Risk 
Factor Surveillance System (BRFSS).   
For any particular datafile, it is desirable to have a set of core variables for which 
the assessment changes little from year to year so that burden of disease calculations can 
be reliably obtained and tracked on a regular basis.  While no single survey likely 
contains enough information to calculate the burden of disease due to an indicator, it may 
be possible to combine survey data.   The data sources listed below are not all 
comparable and differences may occur when a specific outcome measure is obtained 
from two different sources.15  
 
THE NATIONAL HEALTH INTERVIEW SURVEY (NHIS) 
 
 The NHIS is an annual nationally representative survey of the civilian non-
institutionalized population that was first conducted in 1957.  The annual survey consists 
of a core file that varies little from year to year (though major changes are made to the 
core file once every 10 years).  The entire sampling frame consists of 110,000 persons in 
40,000 households.  Income, race and ethnicity data are collected, and black and Hispanic 
households are oversampled.  Adults in the household serve as respondents; proxy 
responses are allowed for absent adults and are required for children or persons unable to 
respond themselves.   
 Due to the relatively large sample size and large number of prevalent conditions 
examined, this survey is useful for burden of disease estimation for most common 
conditions.  The survey is limited by recall bias, inclusion of proxy responses, and a lack 
of a validation mechanism for conditions (e.g., gastroenteritis may be reported as “the 
flu”). 
 
THE MEDICAL EXPENDITURE PANEL SURVEY (MEPS) 
 
 The survey consists of a household component, an insurance component, a 
nursing home component and a medical provider component.  The medical component is 
useful for supplementing and/or validating information provided in the household 
component. 
 The MEPS household component utilizes the same sampling frame as the NHIS 
but the total sample size is smaller.  It includes additional information, including survey 
questions from 2 health status instruments, the EuroQol and the SF-12.  It also includes 
information that, when linked with other ongoing surveys, could be used for economic 
studies of the 10 LHIs, should such information be desired in future research endeavors.  
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Moreover, these data are linked to other components of the MEPS, such as data from the 
respondents’ medical and insurance providers.   
 Data for comprehensive socio-demographic variables, including income, 
education, race, and ethnicity, are collected.  The MEPS has recently been increased to 
encompass 15,000 households and approximately 40,000 persons (Steve Cohen, personal 
communication).  
 
THE NATIONAL HEALTH AND NUTRITION EXAMINATION SURVEY (NHANES) 
 
 The NHANES is a survey of the civilian non-institutionalized population of the 
United States that contains detailed dietary, laboratory, and medical examination data.  
Beginning in 1999, the survey will be conducted annually and will be linked to the NHIS 
and the Continuing Survey of Food Intakes by Individuals, a dietary survey conducted by 
the United States Department of Agriculture.  The survey is linked to the NHIS at the 
Primary Sampling Unit level, rather than at the individual level.  Furthermore, 5000 
individuals are added to the sample each year.  Non-Hispanic blacks, Mexican-
Americans, the young, and the elderly were oversampled.  Complete socio-demographic 
information is available for tabulations by race, ethnicity and socioeconomic status.  
These data are subject to little non-random error since the parameters are 
measured by health professionals and are not subject to recall bias.  For instance, 
correlates of smoking status can be measured via cotinine levels in the blood rather than 
reports of the number of cigarettes smoked.   
The NHANES cohort is linked to death certificate data, allowing risk factors to be 
associated with causes of death. These data may serve to validate mortality data obtained 
from death certificates or to apportion the risk of death for certain conditions using 
attributable risk models.  For instance, in calculating the burden of disease due to 
substance abuse (indicator 4), it may be possible to use the NHANES-linked mortality 
data to determine the proportion of cirrhosis cases attributable to alcoholism. 
 
BEHAVIORAL RISK FACTOR SURVEILLANCE SYSTEM (BRFSS) 
 
 The Behavioral Risk Factor Surveillance System (BRFSS) is a telephone-based 
survey of over 150,000 persons that is conducted at the state level.16  Core questions are 
conducted on a rotating basis and are available once every two years. Included in the 
sample are variables specific to tobacco use, alcohol consumption, immunization status, 
health care access, weight control, exercise, diabetes, cardiovascular disease and socio-
demographic composition.  Socio-demographic variables include race, ethnicity, 
education, and income.  This survey also incorporates an accounting of “healthy days.”  
These are not suitable for calculating HALYs, however.   
Using this survey, it is possible to apportion the risk of various leading diseases 
by risk factor.  The survey is conducted annually. Since states conduct the survey, 
combining these data is methodologically challenging.  Moreover, while each state asks 
the same set of core conditions, many variables are state-specific. 
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NATIONAL HOUSEHOLD SURVEY ON DRUG ABUSE (NHSDA) 
 
The NHSDA is conducted annually and is a representative sample of persons aged 
12 and older residing in the US.  It contains both incidence and prevalence data of non-
medical drug use, all relevant socio-demographic variables, and some conditions 
associated with drug use.  
 
COMMUNITY TRACKING SURVEY (CTS) 
 
The CTS is a sample of 36,200 families in 60 communities.  In this survey, 
subjects are representative of the community in which they live; however, they are not 
weighted to the United States population as a whole.  The survey includes the Short Form 
12 (SF-12), which is a health status measure, and relevant socio-demographic variables. 
 
ANNUAL SURVEY OF OCCUPATIONAL INJURIES AND ILLNESSES (ASOII). 
 
The ASOII is an annual survey conducted by the Bureau of Labor Statistics of 
approximately 250,000 private establishments. This survey excludes the self-employed, 
small farmers, and government workers, but it contains variables pertinent to most 
workplace injuries.  The survey is subject to underreporting. 
 
DEATH CERTIFICATE DATAFILES 
 
 Death certificate datafiles, which include the multiple cause of death datafile, are 
useful for calculating the years of life lost in burden of disease analyses.  They contain 
information on the decedents’ age, education level, and the cause of death; however, they 
do not contain information on decedents’ income, limiting analyses by socio-economic 
status. 
 The multiple cause of death datafile and other death certificate datasets are not 
obtained from a sample.  Rather, these datasets contain information on all reported deaths 
in the United States each year, so they are not subject to random error.  However, since 
the precise cause of death is sometimes difficult to determine, and since the person filling 
out the form may misclassify the cause of death, some causes of death are subject to non-
random sources of error, and the data do not contain information on individual risk 
factors.  Therefore, attributable risk estimates cannot be obtained using these data.  These 
data are useful for tracking annual changes in mortality rates once attributable risk has 
been determined via other sources. 
 
NATIONAL MORTALITY FOLLOWBACK SURVEY (NMFS) 
 
 This survey enhances death certificate information with a sample of responses 
from next of kin who were familiar with the decedent’s life history. The latest survey was 
conducted in 1993 and sampled the next of kin of persons who died in 1993 aged 15 or 
older.  It is based on 22,957 death certificates and contains comprehensive socio-
demographic information, risk factors for disease, and health utilization.  Blacks, persons 
under 35, and women are oversampled.  These data are limited by respondent bias and 
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are considerably older than other sources of mortality data.  However, they may be useful 
in creating a model that calculates the risk of death attributable to a particular risk factor.   
 
CENSUS OF FATAL OCCUPATIONAL INJURY (CFOI) 
 
 The CFOI, conducted by the Bureau of Labor Statistics’ Occupational Safety and 
Health Statistics Program, is a collection of disparate state and federal data sources rather 
than a survey per se.  It identifies, verifies, and profiles fatal work injuries by cross-
referencing source documents, such as death certificates, workers' compensation records, 




The attributable risk refers to the amount of additional risk of disease conferred 
by having a risk factor for the disease.  For instance, the risk of heart disease is increased 
for people with a sedentary lifestyle, smokers, and overweight people, among many other 
factors (e.g., diet and genetics).   
Some indicators will not require attributable risk calculations.  For instance, 
under-immunization refers to society’s failure to administer measles, mumps, rubella, 
tetanus, and other vaccines on an appropriate schedule to appropriate groups.  With 
notable exceptions, such as influenza virus and pneumococcal vaccines, most vaccine 
preventable illnesses are entirely attributable to under-immunization.  When performing 
calculations for vaccine preventable illnesses, the burden of disease calculations will 
require inputs for vaccine efficacy and herd immunity effects but not the attributable risk 
of illness.  Most LHIs, however, will require attributable risk calculations. 
Attributable risk can be applied in various ways. First, a simple estimation of the 
burden of disease for various diseases or conditions attributable to a risk factor can be 
obtained.  The burden of disease attributable to a risk factor can then be determined by 
summing across conditions.  We will refer to this approach as the “simple approach.”  
Second, logistic regression models can be developed that include the risk factor in 
question and all or most of the diseases and conditions attributable to that risk factor as 
variables.17  In this approach, a separate model is developed for a relevant morbidity 
dataset and a relevant mortality dataset.  The burden of disease is then estimated using 
resulting odds ratios (which can then be converted to risk ratios).18  Finally, it is possible 
to use a combination of datasets and, in some instances, parameters from the medical 
literature, to create a mathematical model that can be repopulated with disease prevalence 
or mortality data on a yearly basis.  We will refer to the latter approach as the “indirect 
approach.” 
 
SIMPLE ATTRIBUTION OF RISK 
 
 The overall proportion of disease in the population attributable to the risk factor 
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Equation 1 
 
where, It is the total risk in the population and Io is the incidence among persons without 
the risk factor.  This is sometimes referred to as the population attributable risk. 
 However, it is not always possible to obtain the incidence of a disease with and 
without a particular risk factor.  Therefore, the prevalence of exposure to a risk factor and 




P • RR !1( )




where P is the prevalence of exposure and RR is the relative risk of the disease.   
 For the purposes of burden of disease measurement, it is sometimes convenient to 
calculate the proportion of cases attributable to a risk factor among persons exposed to 
the risk factor.  For instance, for the purpose of calculating burden of disease estimates 
associated with the LHIs, investigators may need to estimate how many tobacco users 
developed heart disease as a result of having smoked, rather than the overall risk of heart 
disease attributable to smoking.  This is sometimes referred to as the attributable fraction 









While each risk factor may be associated with multiple diseases (and even other 
risk factors), these formulas allow for the calculation of the risk attributable to each 
disease when independence across risk factors and conditions is assumed.19  The burden 
of disease due to each risk factor can then be summed across diseases.  
To increase the specificity of this approach, it is possible to calculate a risk 
schedule for various levels of exposure to a risk factor.  For instance, if n is a particular 
level of exposure (e.g., a cholesterol level of 200 to 240), then Equation 2 becomes: 
 
AR = 











If multiple risk factors are present, counting burden of illness from each one 
separately may overestimate the total burden of illness since independence is a tenuous 
assumption.  To apply equation 4 to LHIs for which exposures overlap (i.e. exercise and 
tobacco use), information on joint exposures is needed.  Where this is not available, a 
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more conservative approach may be to simply exclude overlapping exposures.19  Age-
stratification will pose additional challenges, and appropriate age intervals must be 
determined by estimating the sample size in various age intervals across datasets. 
The advantage of this approach is that it is relatively transparent.  The 
disadvantage is that it is difficult to determine the extent to which multiple diseases, 
conditions, and risk factors overlap.  It may also be more resource intensive than deriving 
risk using regression analyses. 
 
USING REGRESSION ANALYSIS 
 
The proportion of prevalent cases of a disease attributable to any given indicator 
may be calculated using nationally representative datasets, controlling for covariates via 
logistic regression analysis.  For instance, Must et al calculated prevalence odds ratios 
(POR) for multiple conditions associated with obesity, for persons with varying body 
mass indices, relative to persons of normal weight using data obtained from the 
NHANES III.17 (A POR is an odds ratio constructed from prevalence rates rather than 
incidence rates.)  Outcomes were then adjusted to prevalence ratios using methods 
forwarded by Zhang and Yu.18   
They examined the prevalence of type II diabetes, gallbladder disease, coronary 
heart disease, and osteoarthritis among persons falling into various National Heart, Lung, 
and Blood Institutes’ weight classifications.  This model controlled for age, smoking 
status, race, and ethnicity.  The advantage of using logistic regression models is that it is 
possible to control for such socio-demographic covariates as well as comorbid conditions 
in calculating prevalence ratios.  This method has been employed to test the effect of 
health insurance status on both morbidity20 and mortality21 and will be referred to in this 
report as the “regression method.”  This method may be appropriate when analyzing a 
single risk factor for multiple conditions (e.g., smoking). 
One issue that arises when looking at multiple conditions or risk factors is 
whether the risk factors are independent and additive in conferring risk of disease.  For 
instance, it is important to determine whether the risk of a coronary death for someone 
who is both obese and a smoker can safely assume that these variables are independent.   
When definitive information regarding risk factor independence is absent, expert opinion 
may serve as a useful starting point for estimating the contributions of different risk 
factors to disease. 
This approach may be best employed when 1) a dataset is available that contains 
the relevant risk factor and all relevant conditions, 2) the sample size of the dataset is 
adequate, and 3) the model can be validated using standard distributional and 
probabilistic tests used in logistic regression analyses.  Most federal datasets require the 
use of software packages that can analyze complex sample schemes, such as SUDAAN 
or STATA.   
Advantages of this approach include its relative simplicity and the ability to 
delineate interactions and error more objectively relative to other approaches.  
Disadvantages include the inability to apply the approach to all indicators, the inability to 
account for error in burden of estimates across datasets (i.e., the extent to which the use 
of one dataset might differentially favor some effects a risk factor has on disease 
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estimates when one dataset is used relative to another dataset), and the inability to 
estimate all effects when the sample size is small or the model is imperfect. 
One issue that arises in applying the regression approach to national datasets is 
the compromise between trackability and non-random error of various datasets.  For 
instance, while few experts dispute that the NHANES is the best dataset for calculating 
the attributable risk of overweight and obesity (since health professionals measure height 
and weight in this study), it may not be as useful for tracking disease on an annual basis 
as surveys that are broadly applied to the population on an annual basis.  The NHIS 
requires subjects to self-report their height and weight, but it is conducted on an annual 
basis, allowing data to be easily tracked.  One modestly resource intensive method of 
circumventing this problem would be to use the NHANES to validate models generated 
from the NHIS or the MEPS, an area in which work has already been done.22  Were we to 
extend this approach by including multiple datasets to increase the breadth of variables 
and to cross-validate the results, we would obtain the indirect approach to deriving 
attributable risk, which is much more resource intensive. 
 
USING THE INDIRECT APPROACH 
 
 It can be argued that the attributable risk of disease may not vary a good deal over 
the relatively short ten-year period for which Healthy People 2010 is conducted, and that 
the use of a single, well-designed indirectly derived (or static) model can provide a sturdy 
skeletal framework for capturing the burden of disease.  In the indirect approach, a static 
attributable risk model is built using multiple sources of data.  This model can than be 
populated with annual disease prevalence and mortality data, so that the burden of disease 
can be tracked from year-to-year.   
 When attributable risk models are built using the best combination of data sources 
available, the specificity of the analysis may be enhanced.  It is also possible to use 
multiple datasets to cross-validate uncertain parameters, such as HRQL values or self-
reported rates.  Year-to-year changes in the burden of disease may then be measured by 
tracking changes in the disease prevalence ratio (or incidence rates) and mortality rates.  
 Cross-validation can be achieved by comparing values generated using different 
datasets.  For instance, the HRQL of tobacco users can be obtained by generating values 
from the YHL measure, which is linked to the NHIS, and the EuroQol (another HRQL 
measure that is described in detail below), which is linked to the MEPS.  Under the 
guidance of experts, these scores can be used to obtain a range of error and a best-
estimate of the HRQL and attributable risk.   
 It may also be possible to utilize variables that have been mapped across datasets 
or to obtain estimates from the medical literature23,24  when more information is needed 
than is available from a solitary source.  However, the type of error inherent to a data 
varies greatly across datasets and not all authors present results of analyses with and 
without sociodemographic covariates that may be relevant for Healthy People 2010, such 
as race and income, limiting the usefulness of such an approach. 
The advantage of the indirect approach is that it adds flexibility by increasing the 
variables available to researchers and may improve validity by providing a rough range 
of error.  Disadvantages include the intensive nature of the analysis and the inability to 
measure main effects in any model with certainty.  It can also be argued that a dynamic 
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relationship exists between risk factors for disease that cannot be accounted for in a 
single snapshot of disease prevalence attributable to a particular risk factor.  For example, 
more African-Americans appear to be exercising while simultaneous, and paradoxical, 
increases in obesity and smoking have been reported for this group.2 Reliance upon 
attributable risk models derived using the indirect approach may therefore belie the 
objective of tracking the nation’s progress toward improving the LHIs.  Nonetheless, 




To begin a discussion of the morbidity component of a burden of disease analysis, 
it is necessary to describe how morbidity is combined with years of life lost in estimating 
the burden of disease.  Health-adjusted life years are calculated by combining the amount 
of time lived with disease or a health condition with years of full health lost when a 
person dies of a condition.  Each year of life lived with disease is assigned a HRQL 
weight that assumes a value between 0 and 1.  Depending on how the measure is 
calculated, 1 is either equal to full health (as in the QALY) or death (as in the DALY), 
and 0 is assigned to the converse state.  For instance, in the QALY, 1 is assigned a state 
of full health and the HRQL score 0.75 is equivalent to 0.75 years of full health.4,6 
The details of HRQL weight assignment have been described in detail 
elsewhere,4,5 but it is important to note that there are two steps in this process.  One is the 
description of a health state, either by the person experiencing it or by researchers.  In 
describing the health state, scenarios or health state descriptions are used to describe 
domains or dimensions that are commonly viewed as central to health.  These might 
include physical and psychological function, role function, and pain or other symptoms.  
 After a health state is described, it needs to be valued.  Valuation is accomplished 
in a number of ways. For instance, in the standard gamble, a subject is asked to choose 
between an undesirable state of health (e.g., living with diabetes) and a gamble between 
full health and death.  The chance of death is varied until the subject is ambivalent 
towards choosing the treatment over the undesirable health state.  The probability of 
death that is acceptable to the subject is equal to the HRQL score. 
We will demonstrate the principle of weighting using an example.  People living 
with diabetes might be assigned a QALY-compatible HRQL value of 0.75 for every year 
lived with the disease.  Thus, if 1000 people aged 60 are living with diabetes and their 
life expectancy with diabetes at age 60 is 10 years, they would be assigned 1000 • 0.75 • 
10 years = 750 years of full health.  Conversely, if the DALY were employed, it can be 
said that 1000 X 0.25 = 250 years of full health are lost to diabetes.   
To improve the specificity of the HRQL score, it may be desirable to capture 
changes in HRQL associated with multiple conditions, such as people who have diabetes 
as a result of being overweight or obese (indicator 2).  Obese persons may plausibly have 
a lower than average HRQL score.  Were it possible to capture both of these effects 
simultaneously, a person with both diabetes and obesity may have an HRQL of less than 
0.75.  Some measures and techniques are better suited to capturing multiple conditions.  
This will be discussed after reviewing potential sources of HRQL scores. 
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SOURCES OF HEALTH-RELATED QUALITY OF LIFE SCORES 
 
 Here, we will discuss three common sources of HRQL scores that have been used 
to calculate HALYs or HALE in burden of disease analyses.  First, HRQL scores may be 
obtained by linking nationally-representative surveys to generic preference-weighted 
HRQL instruments.11  This approach was used to generate HALE in Healthy People 
2000.2,3  Second, it is possible to utilize a community sample of weights as a primary 
source of HRQL weights.  For instance, Health Canada presently uses values obtained 
from the Health Utilities Index (HUI), a QALY-compatible measure based on a sample of 
community preferences, to calculate cause-deleted HALE.10  Finally, the DALY utilizes 
lists of values generated by professionals to calculate HALYs.8 
 Generic preference-weighted HRQL instruments are essentially survey tools that 
are linked to a sample of community-derived preference weights.  These instruments 
typically ask respondents questions concerning various health states, which are grouped 
into a number of different dimensions of health; different instruments capture different 
dimensions of illness. (For an example of such an instrument, see the EuroQol in 
Appendix 3.)  The values entered into the instrument are then assigned a numerical score 
that is mathematically combined with responses to other questions on the instrument to 
derive an HRQL score.   
 The different instruments, which include the HUI and the Quality of Well-Being 
Scale (QWB), and the domains they capture are described elsewhere.5,6  To maximize the 
specificity of HRQL scores, the match between the dimensions of the illness under study 
and the dimensions captured by the preference-weighted instrument should overlap.  
Since different instruments capture different dimensions of an illness, health economists 
have advocated careful selection of instruments in analyses of particular diseases when 
they are applied to cost-effectiveness analyses.4-6  However, in burden of disease analyses 
that focus on many different diseases and conditions, the use of different methods for 
eliciting HRQL scores may affect the comparability of each analysis.25  Therefore, it may 
be preferable to use a single measure. 
The Short Form-36 (SF-36)26 is a commonly used health measure that consists of 
a series of questions that capture functioning, feelings, abilities, and attitudes.  This 
measure, which is available in abbreviated forms including the SF-12, is based on a 0 to 
100 non-interval scale that cannot be directly used as a summary measure.  Instead, this 
measure has been used to graphically represent both morbidity and mortality by 
presenting survival curves coupled with curves representing mild, moderate, and severe 
levels of morbidity.27  More promisingly, the SF family of measures has been modified to 
include death as an anchor point and has been combined into a unitary measure of 
morbidity in an instrument called the SF-6D, which can utilize data from health surveys 
containing SF measures.28 The SF family of measures has also been extrapolated onto the 
QWB scale, a QALY-compatible measure.29 
 The DALY utilizes weights obtained from person trade-off exercises administered 
to health professionals.  Here, informants are asked how many people would need to be 
cured of a particular disease to equal the saving of a life.  These weights were then used 
to devise scores for a large list of conditions.  The Centers for Disease Control and 
Prevention (CDC) recently developed DALY weights for diseases and conditions 
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associated with the following risk factors: tobacco use, alcohol use, unsafe sex, obesity, 
and physical activity (McKenna—personal communication).  
 Lists of scores have also been extracted from the medical literature in an effort to 
compile a complete catalog of HRQL weights at Harvard University.30  This catalog 
contains weights derived from a variety of different instruments and methods, so the 
scores contained therein are not comparable.  We will therefore focus on dataset-linked 




 As of 2001, the MEPS began including the EuroQol instrument among its survey 
items.  This initial step permits a description of the health states experienced by persons 
sampled therein.  Coons et al will begin collecting U.S. preference weights for the 
EuroQol in early 2002, and results are expected to be available in 2003 (Coons—personal 
communication).  Once preferences are available, it will also be possible to link them to 
the EuroQol health states described within the MEPS sample.  This will provide 
information about weights or values, on a scale of 0-1, that are associated with the 
diseases and/or conditions contained within the MEPS survey.  Using this measure, it will 
be possible to calculate and track the HALE of the non-institutionalized civilian 
population in the United States as well as the contribution of particular diseases to the 
overall disease burden. 
In Healthy People 2000, the HALE of the population in general was calculated 
using the YHL measure, which was based on the Health and Activity Limitation Index 
(HALex).11  Health-related quality of life scores were obtained using a technique called 
correspondence analysis, which extrapolated responses on health status and role function 
from the NHIS onto a preference-weighted instrument.  By linking responses obtained 
from the NHIS to the HUI using correspondence analysis, it is possible to capture co-
morbid conditions.  Still, correspondence analysis has yet to be validated, it is only 
community preference weighted via its association with the HUI, and relatively few 
health dimensions are captured by this measure. 
The MEPS and the CTS contain questions specific to the SF-12, a subset of the 
SF-36 questions.  The SF family of measures is widely used in the clinical and research 
settings, and it may also play an important role in mapping data from one data set to 
another.  Methods forwarded by Fryback et al,4 which allow for linkage between the SF 
questions and QWB scores, or, alternatively, the SF-6D, may be used to generate HRQL 
scores from datasets containing the SF-36 or subsets of SF questions. 
 In some instances, the EuroQol/MEPS linked data, YHL/NHIS data, or SF-based 
HRQL instruments may permit the calculation of HRQL for each LHI either using 
regression models or using the indirect approach.  As with calculation of prevalence 
ratios using nationally-representative datasets, the sample size of the MEPS and the 
selected number of conditions available from the NHIS limit analyses of multiple 
conditions and the generation of age-specific scores for less prevalent conditions.  
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ISSUES AND APPROACHES TO CAPTURING HRQL 
 
 Two issues that arise when considering HRQL scores are whether the measure 
captures co-morbidity and whether existing dataset-linked measures are adequate for 
capturing both disease prevalence and HRQL.  In the example above, we saw that it 
would be desirable to capture changes in HRQL due to both diabetes and obesity.  When 
preference-weighted generic instruments are used, both of these effects may be captured 
when entering values for various health domains.  For instance, a severely obese person 
may have more mobility limitations than the average diabetic.   
 Murray and Lopez31 recommend capturing co-morbidity by summing DALY 
scores under the assumption that co-morbidity is additive; however, this assumption has 
not been tested, and it is unlikely to be accurate since many conditions are likely to 
overlap.32 
The use of a preference-weighted generic instrument that has been linked to 
variables in nationally representative surveys, such as that planned for the EuroQol, 
would circumvent many of the problems associated with comorbid conditions.  Measures 
linked to nationally-representative datasets add specificity to the analysis by accounting 
for most co-morbid conditions subjects might have, regardless of exposure.  Thus, in 
addition to accounting for changes in HRQL for most conditions associated with a 
particular exposure, it would be possible to compare the HRQL of persons with a 
sedentary lifestyle with the HRQL of the average person in the US (i.e., with a score less 
than 1) rather than a person in full health.   
While the prevalence of illness may vary from year to year, the overall health-
related quality of life of individuals afflicted with a particular condition can be expected 
to vary little, since this measure is based on an individual’s perception of illness.  Though 
the severity of most conditions may vary slightly, this may not have a large impact on 
HRQL from one year to the next.  Therefore, it may be acceptable to apply scores that are 
not tracked from year-to-year, such as DALY weights.  The use of such scores, however, 
may limit the ability to capture changes in health beliefs or disease severity over time. 
 Obtaining HRQL information for all of the LHIs presents a special challenge, 
since few datasets are linked to HRQL measures.  One way of approaching HRQL 
estimates would be to utilize multiple datasets containing the SF family of scores.  For 
instance, if the CTS were to be used to assess morbidity associated with poor 
environmental quality, it would be possible to generate both disease prevalence estimates 




 The calculation of unadjusted years of life lost due to each condition is less 
controversial than approaches to the calculation of attributable risk or HRQL.  Life tables 
produce reliable estimates of life expectancy and may be employed to calculate the 
HALE for persons with a particular condition or risk factor.9,11,33 Formulaic approaches 
include mathematically-derived curves that estimate life expectancy as well as those 
anchored on a ideal life expectancy, used to calculate DALYs.31  Rosenberg et al review 
various techniques, including the use of Bayesian analysis.34  
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The estimation of the aggregate risk of mortality due to a particular indicator is 
not possible using death certificate data alone, since such data do not contain data on 
exposure to risk factors.  Therefore, there is no reliable way of tracking changes in the 
risk of death attributable to a particular risk factor on a year-to-year basis.  Sources of 
risk factor-associated deaths, such as the National Mortality Followback Survey or the 
NHANES I and II, may be used to attribute risk of mortality in aggregate to some of the 
indicators. 
 
USING LIFE TABLES TO CALCULATE HALYS 
 
 Erickson et al describe the use of the YHL measure for calculating HALE in the 
United States.11  It is also possible to utilize the HRQL scores from the EuroQol, to use 
SF-12/36 data linked to the QWB or the SF-6D, or to utilize community samples to 
capture the overall health of the United States population.9,29,34  Disease-specific HRQL 
scores may be used to estimate cause-deleted HALE using any measure, including the 
DALY.31  For a worked description of calculating HALE due to a specific condition or 
cause-deleted life expectancy, Muennig and Gold.11  Wolfson also provides an excellent 
overview of HALE.10 
 To health-adjust life table values, the total number of person-years in any given 
age interval in an abridged life table is simply multiplied by the HRQL score of interest.  
HALE is then calculated for persons with and without the condition(s) of interest as 
follows: 
 
HALEPopulation - HALEDisease 
Equation 5 
 
where “disease” refers to the condition of interest.  For a complete description of standard 




 The number of DALYs lost to a particular condition is calculated using the 
formula: 
 
The Years of Life Lost (YLL) + The Years Lost to Disability (YLD) 
Equation 6  
 
where YLL is the total years lost to the disease, and YLD is equal to the product of the 
time spent in a health state and the disability weight.31 
 In the DALY, the disability weight utilizes 0 as full health and 1 as death, such 
that the product of the DALY HRQL score and the time in the health state yields the 
years of life lost to disease.  When a HRQL score associated with QALYs is used, the 
score may be subtracted from 1 and then substituted into Equation 6.  A detailed 
description of the use and theory of the DALY measure may be found in Murray and 
Lopez.31 
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 The CDC is nearing completion of a DALY-based US-specific burden of disease 
analysis for various risk factors and conditions that overlap with those discussed here.  
Risk factor analyses include tobacco use, alcohol use, unsafe sex, obesity, and physical 
activity (McKenna—personal communication).  Conditions that underlie some of the 
indicators of Healthy People 2010 or are themselves indicators include ischemic heart 
disease, stroke, neuropsychiatric disorders, diabetes mellitus, cancer, HIV/AIDS, and 
injuries.  In all, the CDC analysis includes all indicators but environmental quality 
(indicator 8), immunization (indicator 9), and health care access (indicator 10). 
  
INDICATOR-SPECIFIC ISSUES AND APPROACHES 
 
 In this section, we suggest ways of synthesizing disease prevalence, HRQL, and 
mortality data and addressing issues and approaches specific to each of the 10 LHIs.  We 
draw heavily from the lessons learned, data sources, and other information provided in 
Healthy People 2000.   
 The optimal methodological approach and data sources will vary from indicator to 
indicator; no uniform method is currently available for estimating the burden of disease 
associated with all indicators.  Moreover, we do not suggest which approach is optimal, 
but we do highlight relevant methodological considerations and data issues.  Table 2 lists 
possible sources of data by indicator.  Consultation with experts in each of these areas 
was beyond the scope of this paper, but it may be important to include such consultation 
when tabulating the burden of disease due to the LHIs.   
 In some instances, it may not be necessary to include all of the conditions 
associated with the risk factor in the analysis, since some conditions contribute little to 
the overall burden of disease associated with a particular risk factor.  When using 
regression models to attribute risk, inclusion of minor conditions may not be possible due 
to sample size limitations.  Since the duration of acute conditions limits their contribution 
to societal morbidity, acute conditions may only be relevant in instances in which the 
prevalence ratio or mortality rate associated with them is high.  Throughout this section, 
we also attempt to highlight those conditions which may be less relevant based on their 




 Between 14 and 23 percent of all premature deaths in the United States may be 
associated with physical inactivity.23,36 Physical activity has been shown to reduce the 
risk of heart disease, diabetes, and high blood pressure.  It may reduce the risk of other 
diseases or condition other risk factors as well.37-40  
Physical activity is currently regularly monitored in the NHIS, which asks 
respondents about different levels of exercise performed and is also included in the 
NHANES. These data may be used to obtain prevalence ratios and attributable risk data 
for heart disease, overweight and obesity, diabetes, colon cancer, and high blood 
pressure.  By linking NHIS and MEPS data, it may be possible to generate overall HRQL 
scores for persons who do and do not participate in exercise, after controlling for 
covariates using any of the methods described in the Morbidity section above. 
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 Since many of the conditions associated with physical activity and obesity are 
similar, a single multivariate model could be used to determine attributable risk and 
HRQL scores for each indicator.  Relevant dependent and independent variables could 
then be substituted. It is also possible to calculate the risk attributable to each condition, 
or to combine multiple datasets with the medical literature via the indirect approach 
mentioned in the Morbidity section above.41  
 
OVERWEIGHT AND OBESITY 
 
Overweight and obesity increase the risk of heart disease, stroke, diabetes, 
gallbladder disease, hypertensive disease, and possibly other illnesses and conditions.42  
The burden of disease and the attributable risk of these conditions may be examined one 
by one, cumulatively using a single regression model, or via the indirect approach.  
The calculation of the prevalence of overweight and obesity may be obtained 
from the NHIS and/or the NHANES.  Health-related quality of life information for 
specific conditions is available from MEPS/EuroQol data, the YHL, or SF-36 
extrapolated measures.  Mortality risk may be estimated using the NHANES or the 
Mortality Followback survey. 
The prevalence of overweight and obesity obtained from the NHIS underestimates 
prevalence values for this condition obtained from the NHANES.2  Therefore, it may be 
useful to obtain the initial attributable risk calculations and burden of disease estimates 
from the NHANES, and then track adjusted values from the NHIS.  Alternatively, this 
information may be calculated using the NHIS or MEPS for annual monitoring purposes 




 Tobacco use is associated with cancer, heart disease, chronic obstructive 
pulmonary disease, and stroke, and it may account for as many as one in five deaths in 
the United States.23,43 The prevalence of tobacco use may be obtained from the NHIS, 
MEPS, or the NHANES, and the attributable risk of the leading conditions associated 
with its use may also be obtained and tracked using any of these datasets.  In an earlier 
cost-effectiveness analysis, QALYs were calculated for smokers, non-smokers, and 
former smokers using the YHL measure;44 it will also be possible to perform these 
calculations using the MEPS. 
 As with other broad indicators, conditions may be examined individually, a best 
baseline estimate may be obtained using the indirect approach, or the overall risk may be 
assessed using a single model.  Whether to capture less prevalent conditions associated 
with tobacco use (e.g.  bladder cancer) depends on the extent to which capturing these 
conditions would impact sufficiently upon the overall burden of disease estimate to 




Healthy People 2010 includes alcohol and other illegal drugs under the rubric of 
substance abuse, but it separates tobacco use into a separate header.  The leading 
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conditions associated with morbidity and mortality due to substance abuse include 
HIV/AIDS, motor vehicle accidents, cirrhosis, and other less prevalent or acute 
conditions.2  The calculation of the burden of disease due to substance abuse presents 
unique challenges given that the incidence, prevalence, and mortality rates of these 
conditions are not tracked in the most common national datasets.  
The NHSDA, which contains both incidence and prevalence data of non-medical 
drug use, all relevant socio-demographic variables, and some conditions associated with 
drug use, may be the best source of prevalence data.  It may be also be necessary to 
estimate morbidity and mortality due to substance abuse via the medical literature and 
expert estimations of the risk of conditions such as HIV, AIDS, endocarditis, automobile 
accidents, workplace accidents, and cirrhosis attributable to substance abuse.  Therefore, 
the indirect method of estimation is perhaps the most useful approach to burden of 
disease estimations for this indicator. 
Importantly, substance use itself is likely to result in decrements in HRQL.  While 
we were not able to find a source of HRQL scores specific to substance abuse, it may be 
possible to estimate this HRQL value using preference-weighted generic instruments that 




The burden of disease contributed by acute infectious conditions may be small 
relative to HIV/AIDS, since they are either of short duration or are asymptomatic and 
lead to little mortality.  With the exception of pelvic inflammatory disease and an 
increased risk of ectopic pregnancy, acute STDs are also associated with few 
complications.  Syphilis and associated conditions may lead to severe long-term illness, 
but the prevalence of this disease is less than 0.004 percent.45 
HIV/AIDS is prevalent, affects young persons, and is increasingly transmitted 
sexually to women of reproductive age.  The extent to which HIV/AIDS or protease 
inhibitors increase risk for other chronic conditions may merit inclusion in a burden of 
disease analysis, as might highly prevalent acute conditions such as Chlamydia. 
 It will not be possible to generate HRQL or prevalence estimates for sexually 
transmitted diseases using national datasets, such as the NHIS or the MEPS.  The 
prevalence of HIV/AIDS and other sexually transmitted diseases may be estimated from 
the medical literature, however, and surveillance data may be used to track changes from 
year to year.  The BRFSS contains a set of questions pertaining to the risk of contracting 
the disease and whether or not subjects had received counseling.  Death certificate data 




 Mental disorders are common and varied, the most prevalent being major 
depressive episodes, panic disorder, manic episodes, agoraphobia, social phobia, simple 
phobia, post-traumatic stress, generalized anxiety disorder, schizophrenia and other 
nonaffective psychoses.  Capturing the burden of disease due to the large array of 
disorders poses special data challenges as well as design challenges.  Moreover, there is 
growing evidence that mental illness, especially mood disorders, may increase the overall 
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risk of comorbid conditions, such as heart disease.46 There is also evidence that these 
conditions are linked to substance abuse, including tobacco use.47   
 The wide variety of mental illnesses coupled with few national survey data also 
presents a challenge.48 While surveys such as the MEPS and NHANES contain some 
information on psychological functioning, these surveys are not adequately 
comprehensive to capture either the prevalence or the HRQL associated with the breadth 
of mental illnesses specific to this indicator.  The EuroQol collects information on 
anxiety, depression, self-care, and usual activities–dimensions that may capture some 
aspects of mental illness.  Data from the SF-12 contained within the MEPS may be useful 
for augmenting information on mental health.  Data linked to other surveys, including 
community samples, may be mapped to larger datasets or useful on their own (see 
discussion of the indirect method above). It may also be useful to analyze variables 
specific to depression contained within the NHANES to obtain the risk of non-mental 
illness attributable to depression, as well as depression itself. The NHSDA contains data 
relevant to substance abuse and mental health. The extent to which mortality from suicide 
can be ascertained using death certificate data is unknown, but it is likely to be 
underreported.  
One bright point in terms of data availability is the National Co-morbidity Survey 
(NCS), which collects data using DSM IIIR and DSM IV criteria as well as the 
Composite International Diagnostic Interview.  This survey was last conducted in the 
year 2000 and may be used to estimate the prevalence of these conditions.  However, this 
survey is only conducted periodically, presenting monitoring challenges.  In addition, 
there is significant morbidity associated with subsyndromal mental illness.49  These data 
may be analyzed alongside, or mapped to, other datasets, such as Beaver Dam and local 
mental health studies if the indirect method is employed. 
 
INJURY AND VIOLENCE 
 
The NHIS collects data on episodes of injury.  The Bureau of Labor Statistics 
(BLS) maintains the ASOII, which is useful for obtaining prevalence estimates and the 
CFOI, which is useful for tabulating fatalities.  The CFOI may contain less 
misclassification bias than death certificate data.  Preference weights may be obtained in 
aggregate from the MEPS or the NHIS.  The BLS data include variables pertaining to 
workplace violence.  It may be necessary to estimate the episodes of violence outside of 
the workplace from the literature. The input of experts will be needed to estimate the 
extent to which such episodes can be tracked using Department of Justice datasets and/or 
the extent to which reports of injury capture episodes of violence. 
 The heterogeneity of injuries presents problems with respect to tabulating HRQL, 
unless injury is measured in aggregate using regression models.  However, an episode-
by-episode approach may still be possible if only prevalent conditions are examined.  
Since injury and violence are episodic, cross-sectional surveys will not capture changes 
in HRQL unless the injury is of long duration or the acts of violence are ongoing. 
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ENVIRONMENTAL QUALITY 
 
One way of estimating the burden of disease due to environmental illnesses is to 
build a multivariable or multivariate regression model that utilizes geographic regions as 
the unit of analysis, pollution indices and other environmentally-related variables as one 
of the dependent variables, and environmentally-related illnesses (in aggregate) as an 
independent variable.  This type of analysis, referred to as a small area analysis, is 
susceptible to ecological bias.  The advantage of a small area analysis is that variables 
from two or more unrelated datasets may be more readily used in the analysis.   
It is also possible to conduct individual level analyses utilizing environmental 
variables as covariates.  SUDAAN or STATA may be used to adjust for differentials in 
aggregation.  While this approach offers the advantage of increasing the specificity of the 
analysis, it may be difficult to link individual-level data with multiple pollution indices 
from different datasets.  One way of managing this problem is to assign a severity score 
to geographic identifiers in datasets.   
While some national datasets, such as the MEPS, contain information on subjects’ 
Metropolitan Statistical Area (MSA), small area analyses may be limited by sample size 
unless variables common to many datasets are used in the analysis.  The CTS may prove 
to be useful for analyses of environmental factors.  The survey includes the SF-12 and 
relevant socio-demographic variables.50  Death certificate data may be employed for 
either small area or individual level analyses of mortality.  Death certificate data, which 
are not associated with information on individual risk factors, may be employed in 
environmental analyses because the risk factors in these analyses must be obtained from 




 The calculation of the burden of disease due to under-immunization is limited by 
underreporting in the National Electronic Surveillance System (NESS), which is the 
primary source of surveillance data.  Though the NHIS, MEPS, and BRFSS are limited 
by recall bias (for which acute diseases are especially susceptible), it is possible to obtain 
reasonable estimates of common vaccine-associated conditions, such as influenza virus 
infections, using these data.  Rough estimates of uncommon conditions may be obtained 
using NESS data coupled with literature on underreporting in passive surveillance 
systems; however, these conditions may be too rare to merit inclusion in an analysis.   
The majority of fatal vaccine preventable illnesses are due to under-immunization 
of chronically ill or elderly persons, who should receive the influenza and pneumococcal 
vaccines.  Cost-effectiveness analyses have been conducted on both of these conditions 
which include an estimate of the overall burden of disease due to these conditions.51,52 In 
these analyses, the duration of illness was a critical variable and was obtained from the 
medical literature.   
Duration of illness estimates are complicated by the availability of treatment 
options, herd immunity (which affects the susceptibility of the overall population to 
illness), and varying time intervals separating the onset of illness and the onset of 
treatment.  For example, the duration of pneumococcal infections must be estimated 
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among a cohort of persons receiving antibiotics at different intervals, and these intervals 
may vary by socio-demographic predictors.  
Because the majority of vaccine-preventable diseases are short-lived, cross-
sectional surveys cannot be used to estimate the HRQL scores.  Therefore, it will most 
likely be necessary to obtain these scores using preference-weighted generic instruments, 
or to utilize DALY weights. 
It may not be possible to measure the HRQL or incidence of these conditions in 
aggregate, so it may be necessary to tabulate the burden of disease due to these conditions 
on a disease-by-disease basis.  The mortality rate attributable to under-immunization for 
conditions that are associated with secondary illness (e.g., influenza) may require 
estimations of excess deaths.  Excess deaths are calculated by subtracting the number of 
deaths due to the condition at hand and conditions associated with the illness during 
seasons of low incidence from those that occur during from deaths that occur during the 
season of peak incidence.  For instance, excess deaths due to influenza-associated 
conditions are calculated by subtracting the total deaths due to influenza during the peri-
influenza season from those occurring during influenza season.53  
 
ACCESS TO CARE 
 
 The CTS, NHIS, MEPS, and the CPS contain information on insurance status as 
well as other variables specific to access to care.  The MEPS and/or the CTS may prove 
to be especially useful for constructing a multivariable regression analysis that tabulates 
the overall prevalence of illness and HRQL among persons with access to care and who 
lack access to care after controlling for socioeconomic and other demographic covariates.  
The NHANES and National Mortality Followback Survey may be utilized to obtain the 
relative risk of mortality due to lack of access to care after controlling for covariates. 
 The foreign-born population presents a methodological challenge in such an 
analysis since it consists of over 10 percent of the population, is healthier than the native-
born population, and 40 percent of the population lacks insurance.54-56  Though birth 
outside of the United States can be measured using death certificate data, only the 
NHANES contains country of origin data.  Therefore, it may be useful to conduct a 
multivariable regression analysis using NHANES data alongside an analysis using MEPS 
data.  This would provide information on the extent to which the foreign-born population 
biases the estimates. 
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Table 2. Potential sources of data and HRQL measures for calculating the burden of 
disease for each of the 10 Leading Indicators of Health. 
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Burden of disease analyses provide information that is easy to present and 
understand.  They also provide sufficient information to rank conditions by their overall 
societal impact.  While burden of disease analyses greatly improve the presentation and 
usefulness of health information, the difficulties associated with attributing risk, finding 
adequate data sources, and estimating burden of disease in a methodologically consistent 
fashion across indicators is not trivial. 
First, flexibility may be required in estimating burden of disease inputs.  While no 
one approach is likely to be sufficient for estimating the burden of disease due to all 10 
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LHIs, regression models may be useful for many of them.  Likewise, it may be possible 
to calculate the overall burden of disease due to the conditions underlying each indicator 
and then apportion these estimates among indicators using attributable risk formulas. 
Second, some indicators present unusual methodological challenges.  For 
instance, tabulation of the burden of disease due to sexually transmitted disease may 
require the use of non-annual datasets, expert opinion, limits on the number of conditions 
examined, and/or broad assumptions on the part of the researchers.  Other indicators may 
require the input of experts in the design of the burden of disease analysis, into the 
nuances of the characteristics of disease within society, and in estimation of unknown 
parameters. 
Third, differences in how HALYs are calculated remains a fractious area of 
discussion in the literature.32  The decision surrounding whether to use DALYs or 
QALYs (and if QALYs, what HRQL score scheme to use) in tracing the LHIs has 
implications for the comparability of efforts across US agencies and across nations. 
For example, the World Health Organization primarily relies upon the DALY for 
burden of disease estimates.31  The advantages of the DALY are that it is easy to use and 
allows for international comparisons.  Disadvantages include the use of professionally 
derived HRQL scores, the unavailability of HRQL scores for various conditions, the 
inability to fully capture comorbid illness, and the lack of a dynamic mechanism for 
tracking changes in HRQL. 
Approaches that utilize QALYs afford more specificity with respect to HRQL, 
offer the ability to capture comorbid illness, and may be used to dynamically track the 
HRQL of a population.  The use of the EuroQol within the MEPS will allow a better 
understanding of the health status of Americans in comparison with a number of other 
nations, where this information is already available.   
It is also possible to combine these various approaches to deriving HRQL scores 
and calculating the burden of disease.  However, amalgamated methods shed some of the 
advantages of traditional approaches.  For instance, it is possible to apply the DALY 
formula for combining morbidity and mortality using QALY-based weights.  This 
approach may improve researchers’ ability to dynamically track HRQL, permit 
comorbidities to be accounted for, and would allow for community-based preferences 
rather than scores derived from health professionals, while affording the simplicity of 
DALY formulas.  However, it would render burden of disease estimates in the US and 
other nations based on DALY scores incomparable to those produced using a combined 
approach. 
The use of various HRQL values would broaden the range of HRQL scores 
available, providing flexibility in approaching burden of disease estimates for each of the 
10 LHIs.  On the other hand, mixing and matching HRQL scores from published lists of 
QALY and DALY scores with those obtained from MEPS-linked EuroQol scores will 
reduce the validity, and thus credibility, of burden of disease estimates across indicators.  
It is also likely to affect the rank order of conditions.9 
In this document, we did not describe issues and approaches related to evaluating 
the economic impact of each indicator or ethical dimensions of different approaches to 
tabulating the burden of disease.  Economic data would assist policymakers in further 
prioritizing the 10 LHIs and may broaden the impact of Healthy People 2010.  For 
instance, it may provide useful information for public health law; economic data would 
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allow current revenues from tobacco taxation and employment to be contrasted against 
the health costs of tobacco.  Moreover, it is possible that some conditions that lead to a 
relatively small loss of healthy life have a large economic impact on the healthcare 
system and therefore deserve more attention.  An economic component to a burden of 
disease analysis can, in part, be achieved with electronic datasets and should be 
considered in future Healthy People 2010 endeavors.  
Moreover, there are ethical issues that should be addressed before a specific 
approach is decided upon.  One issue that arises is the question of distributive justice.  
While society may prefer to invest resources in curing rare fatal conditions over 
investments in curing the common cold, burden of disease analyses would likely estimate 
that more HALYs are lost to the cold than to acute neurodegenerative syndromes.  As the 
Panel on Cost-Effectiveness in Health and Medicine points out,5 and as experience with 
purely empiric approaches demonstrates,57 it is not wise to make policy decisions on 
burden of disease estimates alone. 
Although burden of disease quantification with respect to the LHIs contained in 
Healthy People 2010 appears possible using some of the techniques and approaches 
descried within this document, the challenges remain extensive in creating an account 
that is comprehensible and scientifically rigorous.  The thorny issues of attributing risk 
and avoiding double or undercounting will require the input of a broad array of experts 
who can provide a more in-depth examination of the specific of the content areas.  The 
decision regarding which metric to use in generating HALYs is one that should have 
vetting and buy-in from other parts of Health and Human Services, who are developing 
parallel studies of burden of disease.  For example, the Inter-Agency Group on Summary 
Measures provides a forum for these types of discussions.58  It would be useful for the 
ODPHP to present this project within that group to provide preliminary discussion and 
guidance in this area. 
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